Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma

Area of Science:

• Dermatology
• Oncology
• Immunology

Background:

• Early-stage cutaneous T-cell lymphoma (CTCL), particularly mycosis fungoides (MF), presents diagnostic challenges due to its similarity to inflammatory skin conditions.
• Current diagnostic methods for MF rely on clinical assessment and T cell clonality, which can be insufficient for early detection.
• MF can co-occur with or arise after other inflammatory dermatoses, complicating differential diagnosis.

Purpose of the Study:

• To evaluate the utility of high-throughput T cell receptor (TCR) sequencing for the sensitive and specific detection of malignant T cell clones in early-stage mycosis fungoides.
• To establish a more accurate diagnostic tool for early MF compared to existing methods.

Main Methods:

• Analysis of T cell receptor (TCR) gene rearrangements using high-throughput sequencing.
• Comparison of high-throughput TCR sequencing with traditional methods like Southern blotting and polymerase chain reaction (PCR).

Main Results:

• High-throughput TCR sequencing demonstrates superior sensitivity and specificity in detecting malignant T cell clones compared to conventional techniques.
• This advanced sequencing method provides deeper insights into immune repertoire complexities, aiding in early lesion identification.

Conclusions:

• High-throughput TCR sequencing is a valuable tool for the accurate diagnosis of early-stage mycosis fungoides.
• This technique can improve the detection of early MF lesions and facilitate monitoring of therapeutic responses.